Zobrazeno 1 - 2
of 2
pro vyhledávání: '"B L, Sanford"'
Autor:
M R, Baer, S L, George, B L, Sanford, K, Mrózek, J E, Kolitz, J O, Moore, R M, Stone, B L, Powell, M A, Caligiuri, C D, Bloomfield, R A, Larson, John, Lister
Publikováno v:
Leukemia. 25:800-807
Untreated de novo (n=421) and secondary (n=189) acute myeloid leukemia (AML) patients≥60 years received intensified chemotherapy, including daunorubicin 60mg/m2 and etoposide 100mg/m2 during days 1, 2, 3 with cytarabine 100mg/m2 during days 1–7,
Autor:
J E, Rosenberg, S, Halabi, B L, Sanford, A L, Himelstein, J N, Atkins, R J, Hohl, F, Millard, D F, Bajorin, E J, Small, Nancy, Bartlett
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 19(5)
There is no standard second-line treatment for advanced urothelial carcinoma (UC). Response rates to second-line chemotherapy for advanced UC are low and response duration is short. Bortezomib is a proteasome inhibitor with preclinical activity again